As of 2025-09-18, the EV/EBITDA ratio of BioLife Solutions Inc (BLFS) is -305.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLFS's latest enterprise value is 1,203.93 mil USD. BLFS's TTM EBITDA according to its financial statements is -3.94 mil USD. Dividing these 2 quantities gives us the above BLFS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 10.2x - 13.8x | 13.7x |
| Forward P/E multiples | 12.8x - 18.2x | 16.6x |
| Fair Price | (0.38) - 2.76 | 0.94 |
| Upside | -101.5% - -89.2% | -96.3% |
| Date | EV/EBITDA |
| 2025-09-12 | -304.73 |
| 2025-09-11 | -319.69 |
| 2025-09-10 | -316.65 |
| 2025-09-09 | -315.56 |
| 2025-09-08 | -313.37 |
| 2025-09-05 | -316.29 |
| 2025-09-04 | -309.11 |
| 2025-09-03 | -299.01 |
| 2025-09-02 | -302.66 |
| 2025-08-29 | -299.14 |
| 2025-08-28 | -297.55 |
| 2025-08-27 | -303.76 |
| 2025-08-26 | -306.43 |
| 2025-08-25 | -306.43 |
| 2025-08-22 | -309.60 |
| 2025-08-21 | -299.50 |
| 2025-08-20 | -298.04 |
| 2025-08-19 | -292.93 |
| 2025-08-18 | -292.45 |
| 2025-08-15 | -290.50 |
| 2025-08-14 | -302.42 |
| 2025-08-13 | -306.80 |
| 2025-08-12 | -287.09 |
| 2025-08-11 | -266.54 |
| 2025-08-08 | -270.31 |
| 2025-08-07 | -245.50 |
| 2025-08-06 | -250.97 |
| 2025-08-05 | -246.59 |
| 2025-08-04 | -248.54 |
| 2025-08-01 | -247.50 |
| 2025-07-31 | -253.04 |
| 2025-07-30 | -259.85 |
| 2025-07-29 | -263.25 |
| 2025-07-28 | -264.84 |
| 2025-07-25 | -269.09 |
| 2025-07-24 | -265.20 |
| 2025-07-23 | -267.51 |
| 2025-07-22 | -254.86 |
| 2025-07-21 | -246.96 |
| 2025-07-18 | -247.81 |
| 2025-07-17 | -254.98 |
| 2025-07-16 | -250.36 |
| 2025-07-15 | -247.20 |
| 2025-07-14 | -262.28 |
| 2025-07-11 | -261.43 |
| 2025-07-10 | -270.80 |
| 2025-07-09 | -266.05 |
| 2025-07-08 | -268.73 |
| 2025-07-07 | -259.73 |
| 2025-07-03 | -272.26 |